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ABSTRACT
Sight threatening human cytomegalovirus (HCMV) retinitis still remains a cause for concern
among AIDS patients who do not respond to or do not have access to current antiretroviral
(ART) therapy [1]. However, little is currently known about the degenerative mechanisms
behind HCMV retinal destruction during retroviral immunosuppression. The well-established
murine AIDS (MAIDS) related murine cytomegalovirus (MCMV) retinitis model closely mimics
disease progression seen in AIDS patients [4]. Previous work using this model has shown that
while the cell death pathway apoptosis is involved in disease progression, it is not fully
responsible [1]. It has been found that the mRNA of molecules associated with two other cell
death pathways, necroptosis and pyroptosis, are also correlated with the pathophysiology of
MAIDS-related MCMV retinitis [1]. We propose that retinal degeneration seen during CMV
retinitis involves necroptosis/pyroptosis programmed cell death correlating with the increased
mRNA/protein expression of associated molecules observed in this study.
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INTRODUCTION

Human cytomegalovirus (HCMV) is a large DNA betaherpesvirus that establishes
lifelong myeloid lineage latency in individuals after initial infection of immunocompetent
individuals [1][2]. These individuals usually remain asymptomatic carriers and by the age of 40,
approximately 80% of the population is infected in this way [4][19][82]. In some individuals
however, immune suppression can increase the risk of HCMV reactivation and subsequent
inflammatory/degenerative pathologies respective to the type of immunosuppression [1][3]. Of
concern to our lab is the HCMV induced retinal destruction (retinitis) that can occur during
AIDS retroviral mediated immunosuppression [1].
HCMV exists under the Herpesviridae family of viruses along with Herpes
simplex 1 and 2, Varicella-zoster and Epstein-Barr among others (Fig. 1)[20][21]. Herpesviridae
viruses share a similar basic structure with a large double stranded (ds) genome contained by an
icosahedral nucleocapsid, tegument proteins and then finally an envelope with associated
glycoproteins needed for host cell binding and invasion (Fig. 2)[22]. Some of these glycoproteins
needed for successful viral entry (gB, gH, gL) are also highly conserved between Herpesvirdae
viruses [57]. Additionally, other closely related species-specific CMV fall within the same
Betaherpesvirinae subfamily (Fig. 1)(Fig. 3) and due to the stable nature of dsDNA viruses, there
is a little possibility of viral change [23][24]. Thus, other CMV viruses can be of use in modeling
human pathologies in non-human systems.
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Family

Subfamily

Genus

Virus
Herpes simplex virus type 1

Simplexvirus
Herpes simplex virus type 2
Alphaherpesvirinae

Herpesviridae

Varicellovirus

Varicella-zoster virus (VZV)

Human Herpesvirus 6
(HHV6)
Roseolovirus
Human Herpesvirus 7
(HHV7)
Betaherpesvirinae

Cytomegalovirus

Human cytomegalovirus
(HCMV)

Muromegalovirus

Murine cytomagolvirus
(MCMV)

Lymphocryptovirus

Epstein-Barr virus (EBV)

Rhadinovirus

Kaposi's sarcoma-associated
herpesvirus (KSHV)

Gamaherpesvirinea

Figure 1. Taxonomy of human cytomagalovius (HCMV) in relation to murine
cytomegalovirus (MCMV).
Human herpesvirus (solid lines) in Family Herpesviridae as they relate to HCMV and
MCMV (dotted lines). Information from [20][21].
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Figure 2. Cytomegalovirus Structure.
Representation of the elements in an HCMV/MCMV virion. From [22].

HCMV

MCMV

Figure 3.Comparison of HCMV and MCMV genome.
Boxes: inverted repeats. TRL: long terminal repeats. UL: long unique sequence. IRL: long
internal repeats. IRS: short internal repeats. TRS: short terminal repeats. Modified from
[23]. MCMV IRS not shown [24].
Transmission of CMV infections is similar across affected species and can occur with
direct contact of infected bodily fluids (saliva/urine), sexual activity, blood transfusions/organ
transplants, breast feeding and in-utero transfer [58]. After viral transmission, glycoproteins
initiate viral binding and entry in host cells [57]. Lytic replication, as reviewed in Figure 4, can
then take place during initial infection. In immunocompetent individuals, the immune response is
adequate to stop active infection and the production of virion progeny [59]. Subsequently the
virus enters a period of latency in the genome of myeloid progenitor cells as provirus where it
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continues to be able to replicate its genome during host cell replication [59]. During
inflammatory events and the resulting differentiation of the infected progenitor cells into
macrophages (Mϴ) and dendritic cells (DC), the viral genome is activated by the same
regulatory signals acting on Mϴ/DC which leads to the production of certain viral replication
promoters (such as immediate-early) and proteins that down-regulate antigen presenting cell
(APC) activity [59][60]. In healthy individuals, robust APC activity is enough to overwhelm
viral attempts of re-activation. In non-healthy individuals who have immunosuppression, the
virus can take advantage of the reduced immune activity and overwhelm host cells defenses
leading to re-activation of viral lytic activity [59].

Figure 4. Viral Replication of HCMV/MCMV.
Viral coat proteins bind to cell membrane, virus invades, uncoating, entry into the
nucleus, nuclear genetic replication machinery takeover, viral genome replication, capsid
assembly, vesicle bound, exocytosis and recoating. From [25].
In humans, AIDS related HCMV retinitis results in retinal tissue destruction that
ultimately leads to blindness. Before the advent of ART (anti-retroviral therapy), up to 30% of
AIDS patients lost their vision this way; unfortunately this is still a significant risk for those who
do not respond to or who do not have access to therapy [1]. Additionally, at lower rates, HCMV
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retinitis can occur outside of AIDS in other immunosuppressed populations such as in donor
organ/bone marrow recipients (15.2% out of non-AIDS HCMV retinitis cases) [1], those
suffering from rheumatological conditions (19.1%), individuals of advanced age (33.1%) and
even healthy individuals with localized immunosuppression (~5%) [3][61]. Regardless of the
mode of immunosuppression, clinical presentation of HCMV retinitis appears to be similar. Not
all cases are symptomatic bus usually there are initial visual disturbances in the form of floaters
and some loss of vision to the periphery or even more central areas of sight. Some reduction in
overall visual acuity may also be reported. During examination, aside from retinal necrosis, other
secondary pathologies may present such as macular oedema, optic nerve inflammation
(papillitis) and retinal detachment [61][62]. As the retinitis progresses, the field of visual loss
progressively increases until blindness results [1][62]. Even minimal inflammation and
destruction of the retina proves problematic due to the relative permanency of damage and the
consequent quality of life issues that may cause. For those individuals who are not under an
effective treatment, the effects of HCMV retinitis are far more concerning.
The retina itself is located at the back of the eye, encompassing nearly the whole interior
of the globe and creating a wide field of vision. It consists of several cellular and connecting
layers as described in Figure 5 with the ganglion layer situated facing into the eye and the
photoreceptors at the back. As light enters the eye, it passes to the back of the retina activating
the rods and cones of the photoreceptor cells which then signal the bipolar cells in another layer
(via synaptic activity). From there the signal is passed to the ganglion cells where they act as the
neuronal interface between retinal visual signaling and the image processing of the brain [29]. Of
note in regards to possible immune mediated activity during disease, two additional but non-
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retina areas may be of interest. The RPE (retinal pigment epithelium) located behind the
photoreceptors is responsible for nourishing the retinal cells and degrading damaged ones [63].

Figure 5. The structure of the retina.
Nuclear layers: Ganglion cell layer, inner nuclear layer (bipolar cells) and the outer
nuclear layer (nucleus containing portion of the photoreceptor cells). These are the layers
that are counterstained with DAPI. From [29].
Behind it, is the choroid which is the vasculature structure providing blood supply and bringing
with it myeloid cells and their progenitors – potentially primed for inflammation and/or infected
with virus [63]. During advanced HCMV retinitis, full-thickness retinal necrosis can be seen
upon examination as large patchy white areas with interspersed hemorrhaging (Fig. 6D as
compared to Fig. 6C). There may also be widespread secondary inflammation in other parts of
the eye such as in the uvea [62].
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A

B

C

D

Figure 6. Retinal folding and full retinitis.
A) Ocular histopathology of MAIDS related MCMV retinitis at 8 days post infection
(dpi) showing both retinal folding and full retinal necrosis. We use retinal folding as a
characteristic of 6 dpi however, there can still be some retinal folding by 10 dpi as
retinitis is patchy. B) Non-diseased/healthy mouse retina C) Non-diseased/healthy human
retina D) Similar ‘patchy’ disease pathology is seen in human patients with AIDS related
HCMV retinitis. From Dr. Dix, Dr. Cousins, Bascom Palmer Eye Institute, Miami, FL
and Dix Lab.
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Understanding disease pathogenesis of HCMV induced retinitis during opportunistic
pathogenicity may allow for better understanding of the cellular mechanisms at play in cell death
and tissue destruction. In order to explore these concepts, a murine model was used to replicate
AIDS-related HCMV retinitis in-lab. As previously discussed, HCMV is closely related to other
species-specific CMV viruses including murine CMV (MCMV) (Fig. 1)(Fig. 3) [22][23][57]. To
induce retroviral immunosuppression similar to AIDS, a murine leukemia cocktail is used
(MAIDS) [1][4]. Mice are infected with MAIDS at 4 weeks of age and allowed to progress to
systemic immunosuppression. Then 10 weeks later mice are directly injected subretinally with
MCMV (Fig. 7) to prompt MCMV retinitis in this model. Lastly, in order to evaluate the
progress of retinal destruction over time, groups of mice are euthanized at different time points

Figure 7. Visual Representation of the site of delivery in subretinal injection.
2 µl injection containing MCMV in MAIDS mice in the subretinal space. Mice under full
anesthesia during the procedure. Modified from [26].
(3, 6 and 10 days post infection - dpi) and eyes are harvested. MAIDS-related MCMV retinitis
eyes are phenotypically characteristic and distinguishable between the different time points. This
is especially clear when observing 6 dpi and 10 dpi. Retinal folding is associated with 6 dpi with
full necrosis expected at 10dpi; although because retinitis is patchy in how it spreads, there can
be untouched areas that still only exhibit retinal folding (Fig. 6A as compared to healthy retina
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Fig. 6B). In PCR work, mRNA was usually found to be more highly expressed at day 6 and
dramatically decreased by day 10 [1], likely due to the drop in retinitis activity at the endpoint of
full retinal necrosis. Day 3 mRNA and protein data was usually not highly stimulated.
Ultimately, these time points were picked based on prior data in order to better define the steps
of disease progression. In that same thought, MAIDS-10 (10 weeks MAIDS duration) mice are
used because previous work showed that MCMV could not induce any retinitis without full
immunosuppression being attained by MAIDS over the course of at least 10 weeks [1][12]. Viral
titer remains the same when compared to mice unsusceptible to MCMV retinitis (MAIDS-4
mice) but only MAIDS-10 mice see progressively worsening retinitis at 6 dpi and 10 dpi (Fig. 8)
[1]. All data shown going forward was collected from MAIDS-10 mice unless otherwise
specified.
The mechanistic process leading to the dramatic destruction of the retina in both HCMV
and MCMV retinitis is not yet fully elucidated. Findings using the MAIDS-related MCMV
model in C57BL/6 mice seem to indicate that CMV infection and replication is not solely
responsible for retinal tissue destruction [1] and that while cell death signaling can be variable it
is a large purveyor of retinal degeneration [7][1]. In MAIDS-10 mice, it was seen that severe
retinal destruction occurred in tandem with significant up-regulation of apoptotic molecules tumor necrosis factor alpha (TNF-α), TNF receptor 1 and 2, cleaved caspase 8, cleaved caspase
3, TNF-related apoptosis-inducing ligand (TRAIL), TRAIL receptor (TRAIL-R), Fas, and Fas
ligand [1]. However, TUNEL assay revealed only partial contribution by apoptosis to cell death
(only ~8% and ~ 4% at 6 and 10 days post infection respectively); overall, apoptosis is
associated with limited cell death activity compared to other cell death pathways in many retinal
degenerative diseases [1][5]. Cross-talk between cell death pathways is an integral function in
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Figure 8. Comparison of MAIDS 4 and MAIDS 10 MCMV infected mouse eyes.
A) Severity of retinitis: MAIDS 4 eyes showed low levels or retinitis in comparison to
the more fully developed MCMV disease pathophysiology in MAIDS 10 mouse eyes. B)
There was no significant difference in MCMV titer levels between MAIDS 4 and
MAIDS 10. These experiments were performed by Dr. Hsin Chien under the direction of
Dr. Richard D. Dix, Georgia State University [1].
regulating specific coordinated cell death activity – turning off one pathway results in turning on
another [2]. Identification of mRNA from other cell death pathway molecules seems to be
indicative of both necroptosis (Fig. 9) and pyroptosis (Fig. 10) activity [1]. Given that the
involvement of both has been documented in other retinal degenerative diseases [2][5][6], it
could be postulated that they also play a role in MCMV retinitis alongside apoptosis.
Necroptosis is an alternative programmed pathway induced when apoptosis is inhibited
by caspase blocking activity [8]. As a result, necroptosis shares the same receptor ligand binding
activation and initiation of signal transduction as apoptosis. Extracellular ligand binding of
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Figure 9. Necroptosis cell death signaling pathway.
Schematic of the programmed cell death pathway with associated molecules. Modified
from [11].

Figure 10. Pyroptosis cell death signaling pathway.
Active caspase 1 and caspase 11 cleave GSDMD to initiate cellular death and
inflammation by pyroptosis. From [27].

TNFR, Fas, TRAIL or TLRs induces the intracellular formation of a death complex with FADD,
TRADD or TRIF adaptors and assorted accessory proteins and Receptor-interacting
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serine/threonine-protein kinase 1 (RIPK1). Cellular stimuli that upregulate the deubiquitinating
enzyme CYLD or the cellular inhibitor of apoptosis protein 1 (cIAP1) cause RIPK1 to dissociate
from the first complex in order to form a second death complex with uncleaved caspase 8 and
FADD [10][2]. From this point on, the two pathways diverge dependent on caspase 8 activity.
Necroptosis signaling is prompted when Fas-associated protein with death domain (FADD)
cleavage of pro-caspase 8 is inhibited via the competitive formation of uncleaved caspase 8 /
cellular FLICE inhibitory protein (cFLIPSorR) heterodimers [8]. After which, RIPK1 recruits
RIPK3 into the necrosome complex through their RIP homotypic interaction motif (RHIM)
domains where autotransphosphorylation of both Ser227 also occurs via each other’s kinase
domain [10][2][64]. Lastly, the now active RIPK3 then recruits and phosphorylates mixed
lineage kinase domain-like (MLKL). Active MLKL forms an oligomer complex with other
active MLKL before it migrates to the plasma membrane and in a process still not yet fully
understood, ruptures the membrane via pore formation [11][64]. This results in a necrotic cell
death in which the release of damage-associated molecular patterns (DAMPs) trigger a highly
pro-inflammatory response [9]. A brief schematic of this signaling pathway is shown in Figure 9.
This is a well regulated form of necrosis controlled by a caspase independent signaling pathway
– as opposed to passive necrosis, which occurs due to cell damage and a subsequent failure to
maintain homeostasis with the result being cell swelling and eventual membrane disruption
before death (Fig. 11)[5][28].
Pyroptosis on the other hand is similar to both apoptosis and necroptosis but exhibits its
own specific pathway. Similarly to apoptosis, it is a caspase dependent mode of cell death that
generally occurs in response to pathogen infection. Furthermore, it triggers an inflammatory
response just as necroptosis does. The signal transduction pathway is activated when pathogen-
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Figure 11. Types of cell death outcomes.
Schematic representation on cell destruction in relation to type of cell death. Programmed
cell death: Apoptosis, Autophagy, Necroptosis and Pyroptosis. Non-programmed cell
death: Necrosis/Oncosis. Of interest to this study Necroptosis and Pyroptosis. From [28].

associated molecular patterns (PAMPs) are exhibited intracellularly due to cellular infection [2].
Pattern recognition receptors (PRRs) such as nod-like receptors (NLR) and absent in melanoma
2 (AIM2) protein detect these PAMPs and form oligomer complexes that become caspase
activating inflammasomes upon the recruitment of apoptosis-associated speck-like adaptor
protein containing a CARD (ASC) [2]. Once formed, pro-caspase 1 is bound to the
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inflammasomes at the adaptor protein, ASC, and cleaved into active caspase 1. Final pyroptosis
activity is then initiated by caspase 1 cleavage activity of both gasdermin D (GSDMD) and the
inflammatory cytokines pro-interleukin (IL)-1β and pro-IL-18. Activated GSDMD proteins
oligomerize at the cell membrane and form pores which serve as an avenue of cytokine release
and ultimately cause cell swelling and lysis [27][2]. Thus pyroptosis is also an inflammatory
form of cell death but unlike necroptosis, instigates a more specific immune response by means
of extracellular cytokine signaling. A brief overview of both the canonical and non-canonical
pathway can be seen in Figure 10. As can be seen in the non-canonical pathway, caspase 11 can
also cleave and activate GSDMD but cannot stimulate cytokine release [27][2]. However,
pyroptotic cell death can still occur due to GSDMD disruption of the plasma membrane [2].
Both necroptosis and pyroptosis pathways are potent forms of cell death and a
pro-inflammatory state [2][6][9][56]. This might help explain the devastating levels of retinal
destruction and the speed with which it spreads. In contrast, apoptosis cell death does not signal
for cell death in surrounding cells nor does it seem capable of inducing inflammatory pathologies
known to co-occur with CMV retinitis [1][2][8][10]. In past studies, this lab has already shown
that necroptosis associated RIPK1and RIPK3 mRNA are expressed in MAIDS-related MCMV
retinitis eyes. RIPK1 mRNA is significantly upregulated with the greatest increase at 6 days post
MCMV infection (dpi); RIPK3 by comparison exhibits minor but clear upregulation as well [1].
Additionally, the mRNA of several pyroptosis associated molecules were previously found to be
upregulated in MAIDS-related MCMV retinitis as well [1]. Caspase 1, caspase 11, GSDMD, IL1β and IL-18 all displayed significant upregulation by 6 dpi and dropped again in mRNA
expression by 10 dpi [1][performed by Jessica Carter under the direction of Dr. Richard D. Dix,
Georgia State University-manuscript in progress]. Following that data, it could be presumed that
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programmed cell death via necroptosis and pyroptosis play roles in MCMV induced retinal cell
death.
Therefore, we will expand on the central hypothesis that necroptosis-associated
molecules RIP1, RIP3, and/or MLKL and pyroptosis-associated molecules caspase 1, caspase
11, GSDMD, IL-1β and/or IL-18 are stimulated intraocularly during the pathogenesis of
MAIDS-related MCMV retinitis. Specific Aim 1 will investigate whether necroptosis cell death
is involved in the retinal destruction observed in the experimental model. Although mRNA for
necroptosis-associated molecules, RIPK1 and RIPK3, were found to be stimulated during
MAIDS-related MCMV retinitis, the full extent of necroptosis in MCMV retinitis has yet to be
elucidated. Therefore, the hypothesis of specific aim 1 postulates MLKL will be upregulated in
MCMV infected eyes and that all tested necroptosis molecules RIPK1, RIPK3 and MLKL will
be stimulated in retinal layers displaying MCMV retinitis in MAIDS-10 mice. This will be tested
by assessment of MLKL mRNA via real-time RT-PCR quantitative analysis and RIPK1, RIPK3,
MLKL protein via IHC staining and western blot in the murine model eyes. All data will be
evaluated by comparison with non-infected controls. Specific Aim 2 will then follow the first in
investigating the potential role of pyroptosis cell death in retinal tissue destruction in the
experimental model. Multiple pyroptosis-associated molecules were found to have increased
mRNA expression in MAIDS-related MCMV retinitis eyes but pyroptosis activity in the form of
protein expression is still ongoing. Hypothesis of specific aim 2 postulates that pyroptosis
molecules caspase 1, caspase 11, GSDMD, IL-1β and IL-18 will be stimulated in retinal layers
displaying MCMV retinitis in MAIDS-10 mice. This will be tested by protein analysis of caspase
1, caspase 11, GSDMD, IL-1β and IL-18 via IHC staining in the murine model eyes. All data
will be evaluated by comparison with non-infected controls.
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2
2.1

MATERIALS AND METHODS

Cell Lines
All cell lines used were for the cultivation of viral stocks to be used for murine in vivo

infection and disease initiation.
For MAIDS induction as a murine retroviral model, SC-1 fibroblast (ATCC #CRL-1404)
and LP-BM5 – MuLV infected SC-1 - (AIDS Research and Reference Reagent Program,
Germantown, MD) were utilized. SC-1 cells with and without murine leukemia viral (MuLV)
infection were grown in Dulbecco’s modified eagle media (DMEM, Corning Life Sciences) with
10% fetal bovine serum (FBS)(Atlas Biologicals), 24 mM L-glutamine, 1%
penicillin/streptomycin, 0.1 mg/mL gentomicin.
MCMV stocks for sub-retinal injections were grown and titered in mouse embryonic
fibroblast (MEF) (ATCC #SCRC-1002) cells. Cells were maintained in DMEM with 15% FBS,
4 mM L-glutamine, 1% penicillin/streptomycin, and 0.1 mg/mL gentomicin.
2.2

Viruses
LP-BM5 (MuLV infected SC-1) and SC-1 cell lines were thawed and grown in SC-1

media until confluent. Established cultures of the two cell lines were mixed in a 1:1 ratio and
separated in 16 T-150 flasks with 12 mL of SC-1 growth media. After 6 days, the cell
monolayers in the flasks were gently scraped and transferred along with media into 150 mL
conical tubes and stored at -80°C until use. For injection, MuLV retroviral cocktail was thawed
and centrifuged to dispose of cellular debris.
MCMV stock, for use in subretinal injections, was propogated in BALB/c
(Harlan/Envigo) mouse salivary glands [12]. 20 mice were injected intraperitoneally (IP) with
0.2 mL of Smith strain of MCMV ( ~103 plaque forming unit (PFU)). Fourteen days post
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infection (dpi), the mice were euthanized and the salivary glands harvested. Salivary glands were
homogenized in 1.5 mL DMEM with 10% fetal bovine serum and centrifuged before aliquoting
the supernatant into 0.5ml and storing in liquid nitrogen. Each viral stock was titered via plaque
assay in advance of sub-retinal injections.
2.3

Animals
Adult female wild-type C57BL/6 (Jackson Laboratory) mice of 2 weeks of age and adult

female wild-type BALB/c mice (Harlan/Envigo) of 8-12 weeks of age were acquired and
acclimatized in Georgia State University’s Animal Facilities to the following husbandry
conditions: 5 mice to a habitat, alternative 12-h light-dark cycles, an enrichment article and free
access to food and water. Experimental procedures followed guidelines from the National
Institutes of Health (NIH) and the Association for Research in Vision and Ophthalmology
Resolution (ARVO) on the Use of Animals in Research. Experimental protocols received prior
approval by The Institutional Animal Care and Use Committee (IACUC) at Georgia State
University.
Induction of MAIDS: MAIDS was induced in groups of 4 week old wild-type C57BL/6
mice via intraperitoneal (IP) injection of 1 mL of MuLV retroviral cocktail (LP-BM5/SC-1
mixture at ~103 PFU). Infection was allowed to progress for 10 weeks (MAIDS-10 mice) post
injection before the next experimental step (mice aged 14 weeks); previous work indicated such
late stage MAIDS mice are more susceptible to retinitis than earlier stages (MAIDS 4 mice)
[1][12].
Subretinal MCMV Injections: Systemic MCMV does not induce retinitis despite viral
presence in the choroid and RPE [13]; however, it was found that directly injecting the viral load
into the eye under the retina did in fact result in retinitis equivocal to disease pathologies of
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AIDS related HCMV retinitis [12][14]. Therefore, a subretinal route of infection is a suitable
murine model for representation of the human disease.
For subretinal MCMV infection, the previously described groups of MAIDS-10 mice
underwent a series of steps to prepare them for subretinal injections. Both eyes for each mouse
were dilated over the course of 3 rounds of atropine and tropicamide ophthalmic drops.
Following the final round of eye drops, anesthesia procedures were initiated and mice were given
their first injection of 0.1 mL xylazine (1.72 mg/mL) intramuscularly (IM) in a hind leg. After
each mouse within a group received the first injection, a secondary injection of 0.1 mL
acepromazine (0.28 mg/mL) was given in the alternative leg. Induction into full anesthesia was
achieved with a final IP injection of 0.1–0.2 mL ketamine (8.58 mg/mL). Upon complete nonresponse to stimuli, mice were given a final round of phenylephrine ophthalmic drops before
being subretinally (supraciliary) injected with 2µL of MCMV (prepared as previously discussed)
in the left eye and 2µL of DMEM media in the right eye (contralateral injections). The media
injected eye served as a control for the MCMV injected eye within one individual mouse due to
the findings that MCMV does not pass from the infected to the non-infected eye in the durations
under consideration here [15]. Groups of mice were euthanized at 3, 6 and 10 days post MCMV
infection via a two step process: isoflurane induced anesthesia followed by cervical dislocation.
Subsequently, the eyes were harvested and stored depending on how they would be later
analyzed for necroptosis and pyroptosis associated molecules; RNAlater (whole eye mRNA
analysis via real-time RT-PCR), frozen in liquid nitrogen (whole eye protein analysis via
Western Blot), or stored in 10% buffered formalin solution at 4°C (eye section protein staining
via immunohistochemistry).
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2.4

Real-Time RT-PCR
Whole MCMV-infected eyes and contralateral media injected eyes (control) at 3, 6, and

10 days post infection were stored in RNAlater solution (Ambion) at −80°C . For analysis, each
eye was thawed and homogenized in 1 ml of TRIzol reagent (Invitrogen Life Technologies).
RNA was extracted from each homogenized sample following the PureLink® RNA Mini Kit
total RNA purification system (Invitrogen Life Technologies) protocol. RNA concentration for
each sample was quantified via SmartSpec 3000 spectrometer (Bio-Rad Laboratories) and
equalized between samples. Samples were then stored at -80°C until needed.
Samples were thawed prior to undergoing the steps involved in real-time reverse
transcriptase polymerase chain reaction (RT-PCR). Extracted RNA was used to synthesize
complementary DNC (cDNA) using the SuperScriptTM III first-strand synthesis system
(Invitrogen) and protocol. Mouse specific MLKL and GAPDH primers obtained from QIAgen
(Valencia, CA) and SYBR green PCR master mix (Applied Biosystems) was used to help
determine levels of MLKL mRNA transcripts in each sample during thermocycling using a ABI
Prism 7500 real-time PCR instrument with sequence detection software (Applied Biosystems).
System parameters for cycling was set up for 10 min at 95°C, followed by 40 cycles consisting
of 15 s at 94°C, 31 s at 55°C, and 35 s at 70°C. MLKL mRNA transcript cycles to threshold
(CT) were determined for MCMV infected and contralateral control eyes compared to
constituently expressed GAPDH.
2.5

Immunohistochemistry (IHC) Fluorescent Staining
Eyes were collected at 6 and 10 days post MCMV infection and immediately fixed with

10% neutralized formalin at 4°C for at least 5 days. Eyes were cut into 5-μm-thick transverse
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sections and every 6th section embedded in paraffin on slides by the Pathology Department of the
Emory Eye Center.
Prior to immunohistochemical staining, slides were soaked in Xylene substitute (SigmaAldrich, St. Louis, MO) for 3 5 minute intervals to remove paraffin. Then sections were
rehydrated in decreasing 70% ethanol/PBS concentrations (95%, 75%, 50%) for 15 seconds
each, washed in PBS for 30 seconds, treated with 10 mM sodium citrate retrieval solution for 10
minutes, washed with PBS for another 5 minutes, and finally blocked with 5% normal goat
serum containing 0.2% Triton X-100 (Ambion/ThermoFisher) for 30 min at room temperature.
Another wash in PBS for 3 intervals of 5 minutes prepares the sections for primary antibody
application. Sections were incubated with primary antibodies specific for necroptosis and
pyroptosis specific molecules overnight at 4°C. Necroptosis: rabbit anti-mouse RIPK1 (1:200)
(Antibodies Online, Atlanta, GA), rabbit anti-mouse RIPK3 (1:200) (Antibodies Online, Atlanta,
GA), rabbit anti-mouse MLKL (1:200) (Abcam, Cambridge, MA). Pyroptosis: rabbit anti-mouse
caspase-1 (1:200) (Abcam, Cambridge, MA), rabbit anti-mouse caspase 11 (1:200) (Abcam,
Cambridge, MA), rabbit anti-mouse GSDMD (1:200) (Abcam, Cambridge, MA), rabbit antimouse IL-1β (1:200) (Abcam, Cambridge, MA), rabbit anti-mouse IL-18 (1:200) (Abcam,
Cambridge, MA). A matched isotype rabbit IgG was used as a negative (1:200) (Abcam,
Cambridge, MA) for all primary antibodies. After incubation, three 5-min washes with PBS were
done prior to secondary staining. Retinal sections subsequently were incubated at room
temperature in the dark for 1 h with the secondary antibody conjugated goat anti-rabbit Cy3 (red)
(1:100) (Jackson ImmunoResearch) for fluorescent visualization of each molecule in the retina.
After secondary antibody incubation, sections were washed in PBS for three 5 minute and then
mounted with medium containing 4',6-diamidino-2-phenylindole (DAPI) (Vectorshield; Vector
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Laboratories) to counterstain nuclear material. Sections were inspected and photographed by
fluorescence microscopy (Nikon Eclipse). ImageJ was used to background correct images.
Presence of each of the previously mentioned necroptosis and pyroptosis-associated molecules
was qualitatively assessed by comparison of control (media injected) and MCMV infected eyes.
2.6

Western Blot
Western blot was used to evaluate levels of necroptosis-associated molecules present in

MCMV infected whole eyes compared to contralateral media injected (control). Eyes were
collected at 3, 6 and 10 days post infection (dpi), eyes harvested and stored in liquid nitrogen
until needed. Eyes were used individually, representing one group each per blot.
In preparation for western blot, eyes were thawed before protein extraction. 2X extraction
buffer was prepared using a protease inhibitor (complete Mini, EDTA-free) (Roche) in
phosphate-buffered saline (PBS) (Sigma, St. Louis, MO). Eyes were first homogenized in 0.5mL
cold extraction buffer and then spun at 13,000 RPM for 1 minute. 130µl of the supernatant was
transferred and added to equal amounts of cold DMEM for later viral quantification. Protein
concentration of each sample was quantified following the “Microtitier Plate Protocols” of the
protein assay kit used (Bio-Rad –Bradford). The spun down pellet of the remaining sample
portion was resuspended and an equal volume of 2x extraction buffer was added before storing at
-20⁰C overnight. Samples were pulse sonicated following protein extraction steps and then
centrifuged at 5,000xg for 5 minutes at 4⁰C. Protein concentration of each sample was equalized
to one another via PBS dilution based on the protein quantification results. Finally, 5x sample
buffer was added to each sample in a 1:4 ratio before boiling at 99⁰C for 15 minutes (PCR
Thermocycler). Samples were stored at -20⁰C until needed.
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A Western blot protocol was performed to evaluate MLKL protein levels. Samples were
subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a
nitrocellulose membrane using a Power Blotter Transfer Stack (ThermoFisher Scientific,
Waltham, MA, USA). Samples were blocked in 5% non-fat skim milk and probed for primary
antibodies specific for rabbit anti-mouse MLKL antibody (1:500, Abcam, Cambridge, MA) and
rabbit anti-mouse GAPDH (1:1000, Sigma-Aldrich, St. Louis, MO). Goat-anti-rabbit IgG used
(heavy plus light chains [H+L]) (1:2000, ThermoFisher) conjugated with horseradish peroxidase
was used as a secondary antibody. An enhanced chemiluminescent (ECL) horseradish peroxidase
(HRP) substrate (SuperSignalTM West Pico Plus - ThermoFisher) was then applied to the
membrane for 5 minutes before exposure to HyBlot film (Denville, Holliston, MA).
2.7

Statistical Analysis
Statistical analysis of protein and mRNA levels between MCMV infected and media

injected control eyes was performed where necessary with P values ≤0.05 considered significant.
Quantitative data from real-time RT-PCR of MLKL mRNA values from each MCMV infected
eye compared to the contralateral media injected eye from the same mouse was determined by
the 2-ΔΔCT method. Statistical analysis was done using student t-test yielding P values for each
group (* p<0.05, ** p<0.01). A standard error of deviation (values from at least 3 mice per
group) was also calculated for each group and labeled with an error bar. Graphed results
demonstrate mean fold change of mRNA levels in MCMV infected mice compared to that of the
control eyes.
Protein levels of MLKL were determined via western blot. Band density was quantified
using ImageJ and graphed to visualize protein level differences in MCMV infected eyes
compared to control by calculating total % of GAPDH control for each sample.
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3

MLKL EXPRESSION IN WHOLE EYES DURING MCMV RETINITIS

The final and critical determinant step of necroptosis signaling is the activation and
oligomerization of MLKL [11][64][65]. As discussed earlier, real-time RT-PCR work was
previously done for RIPK1 and RIPK3 to evaluate the potential involvement of these upstream
necroptosis-associated molecules in MAIDS-related MCMV retinitis [1]. However MLKL was
not investigated at that time because little was known then about MLKL and its role in the
necroptosis signal transduction pathway [65]. Current literature has brought to light MLKL’s
significant involvement in necroptosis as well as suggests other potential functions. Here the aim
was to determine if MLKL was stimulated in MCMV-infected eyes of MAIDS mice and thus
potentially confirm or refute the possibility of necroptotic cell death in MAIDS-related MCMV
retinitis.
Real-time RT-PCR is widely used to determine mRNA levels of intra- and extracellular
molecules in tissues and is generally done before protein assays. As an initial step in the
production of cellular products (illustrated in Fig. 12), transcription is indicative of cellular
driven regulatory activity aimed at promoting particular gene expression [16]. Quantification of
mRNA thus allows for an estimation of downstream protein production activity. Through the
process of mRNA amplification by RT-PCR (Fig. 13), even minute amounts of a given mRNA
transcript can be accurately detected in real-time [16][18]. On the other hand, western blots and
IHC provide important insights into final protein expression of a gene but are not as accurate or
precise due to the potential for antibody and antigen variability [17][32]. They are also not
necessarily able to gauge the total effect an experimental state has on gene expression [17] which
may be integral for identifying the likelihood regulatory interplay by other molecules of interest
[66]. More importantly, real-time RT-PCR has a faster turn-around than protein assay [16][17]
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and prevents the wasting of valuable time on subsequent protein work should mRNA be absent.
Hence why preliminary probing for necroptosis-associated RIPK1 and RIPK3 mRNA levels
were previously done by Chien et al. (2012) (Fig. 14). With the postliminary identification of
MLKL as a necroptosis participant by scientific literature, its mRNA expression in MAIDSrelated MCMV infected eyes was therefore investigated.

Replication
DNA
*Nucleus*

Transcription
Replication

mRNA

Translation
*Cytoplasm*

Protein

Figure 12. Central Dogma of molecular biology.
Flow of genetic information from DNA to RNA to Protein.
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Figure 13.Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).
Schematic representation of the reverse transcriptase and polymerase chain reaction used
to amplify mRNA (which is quantified via real-time methods for this study). Modified
from [18].

A.

B.

Figure 14. RIPK1 and RIPK3 mRNA expression in MAIDS-10 subretinally infected eyes
compared with media control eyes.
Days 3, 6 and 10 post MCMV infection are shown. Values represent mRNA fold change
of MCMV infected eyes compared to media injected control eyes. Expression of mRNA
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quantified by real-time RT-PCR and statistically analyzed by student T test with P values
≤0.05 being significant **p≤0.001, *p≤0.05 (n=5). (A) RIPK1 mRNA shows a
significant upregulation at 6 dpi and downregulation by 10 dpi. (B) RIPK3 mRNA shows
downregulation from 6 dpi to 10 dpi. These experiments were performed by Dr. Hsin
Chien under the direction of Dr. Richard D. Dix, Georgia State University [1].

In the case of mRNA expression, subsequent protein assays are necessary to assess true
protein levels as mRNA does not always correlate with protein expression [37][68]. This is due
in part to the adaptable nature of gene expression regulation; both mRNA and protein can be
modified in a number of ways that may ultimately result in alternative products or premature
degradation [66][67][104]. Therefore to confirm any mRNA based predictions of protein
production, it is necessary to quantify the tissue’s protein product. In comparison to mRNA
quantification via real-time RT-PCR and the localization of protein via IHC, westerns can
quantify relative total protein through the use of specific antibody binding and signaling (Fig. 15
antibody schematic) [68]. Thus, it is a well-established method for providing an insight into
overall cellular protein production/processing activity throughout the tissue of interest.
Suggested as the key player in the necroptosis signaling pathway [65], overall MLKL activity in
the eye was of interest. MLKL relative total protein in whole eyes as compared to mRNA
expression also in whole eyes was done by western blot.

Figure 15. Schematic representation of an antibody.
Fc = receptor binding; Fab = antigen binding. Unconjugated primary antibodies bind to
target antigen by the Fab region. Secondary antibodies are primed to target protein of the
primary antibody host species (will bind to Fc region); the secondary antibody binds
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‘antigen/primary Fc’ by its Fab and is conjugated by a fluorescent tag on its Fc. From
[30].
3.1

MLKL mRNA Expression in MCMV Infected Eyes

Figure 16. MLKL mRNA expression in MAIDS-10 subretinally infected eyes compared
with media control eyes.
Days 3, 6 and 10 post MCMV infection are shown. Values represent mRNA fold change
of MCMV infected eyes compared to media injected control eyes. Expression of mRNA
quantified by real-time RT-PCR and statistically analyzed by student T test with P values
≤0.05 being significant **p≤0.001, *p≤0.05. n=3-5

As was previously mentioned, apoptosis was found to not be the sole progenitor of cell
death in MCMV retinitis [1]. In evaluation of other possible cell death pathways, RIPK1
upregulation could be indicative of either apoptosis or necroptosis cell death signaling and the
minor upregulation of RIPK3 alone was not enough to significantly confirm necroptosis (Fig. 14)
[1]. MLKL involvement was thus investigated in order to clarify the suggestive but ambiguous
nature of this previous RIPK1 and RIPK3 data. During programmed necroptotic cell death,
MLKL acts as the ‘executioner’ in the final steps - initiating and ultimately causing cell death
[2][64][65][79]. This final process involves the activation of MLKL by phosphorylation which
induces oligomerization with other active MLKL and causes it to translocate to the plasma
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membrane; resultant selective pore formation and eventual cell lysis is characteristic of necrosislike death [43][11][64][65]. Therefore, in support of RIPK1/RIPK3 mRNA findings,
upregulation of MLKL mRNA was expected to occur during MCMV retinitis.
To test this, eyes from MAIDS model mice were taken at days 3, 6 and 10 days after
MCMV and contralateral mock (media) infection in accordance with earlier selected time points.
Real-time RT-PCR was run on homogenized whole eyes with a commercial primer
complementary for MLKL mRNA sequence; this was repeated three times with groups of three
to five animals each time. Results from MCMV infected eyes were normalized using results
from mock infected eyes and graphed as mRNA fold change; overall findings were significant
and repeatable (Fig. 16). MLKL mRNA was increased 3 dpi by ~36 fold in MCMV infected eyes
when compared to the media injected eyes, and was highly significant with little variability
between samples. The increase in mRNA expression (~38 fold change) by day 6 was also found
to be significant. The mRNA expression seen for day 10, while not significant due to sample
variability, displays a noticeable decrease. This indicates a general trend of high day 6 expression
that seems to greatly abrogate by day 10 and has been seen both in previous and subsequent data
[1]. In comparison of mRNA data for the three necroptosis-associated molecules investigated
(Fig. 14) (Fig. 16), it is pertinent to evaluate their combined results both in terms of regulation
and sequential signaling along the necroptosis pathway.
Discussed beforehand, we know that RIPK1 is the first required molecule to initiate
classical necroptosis signaling [2][11]. However it is also involved in several other pathways and
thus highly regulated with specific responses likely being conserved between individuals
[10][2][43][69][103]. Perhaps for that reason, mRNA values remain tightly clustered and
significant at each time point. On the other hand, lack of significance in RIPK3 mRNA data may
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result from a reduced need for strict RIPK3 regulation due to its limited roles and the
unlikelihood of non-specific signaling [2]. Furthermore, it’s signaling activity is largely transient
[79] and indirectly controlled by other activating/deactivating molecules already under
tight/specific regulation such as caspase 8, RIPK1 and MLKL [43][65][72][75][80]. A
proteasome system has been suggested as a method for direct RIPK3 regulation; variable polyubiquitination of different lysine residues by several non-specific ubiquitin ligases and the
potential for proteasome degradation could result in differential outcomes that vary between cells
[10][77][81]. Even at basal levels, necroptosis signal transduction can still occur as a few RIPK3
can transiently activate many more MLKL [2][10][79]. Even then, total absence of RIPK3 is
relatively well tolerated as can be seen with RIPK3 knockout mice [76]. Overall RIPK3 may be
an incredibly useful alternative for inducing necessary signaling in a compensatory but nonessential capacity; if so, this could indicate there is less selective pressure on RIPK3 expression
between cells and individuals. Increased regulatory control is likely seen again though with the
final effector of necroptotic cell death, MLKL [11][64]. It is crucial to necroptosis [65][78] and
knocking it down/blocking it inhibits necrosis characterized death [65][77]. Current research also
seems to indicate the possibility of alternative MLKL activation and functions [33][70][71].
Taken together it could be assumed that MLKL is integral to cellular function but potentially
harmful if disregulation were to occur. Variation in expression however is still observed to
increase with each successive time point with loss of significance by day 10. Unfortunately a lot
is still unknown about MLKL [65], so there could be several reasons for the trend in its mRNA.
It could simply be that the rate of necroptosis progression differs between individuals, perhaps in
response to differential RIPK3 expression.

30

Despite any differences in mRNA expression between individuals, there is still a very
clear overall trend between day 6 and 10. Initial mRNA upregulation differ between RIPK1,
RIPK3 and MLKL but likely for some of the reasons discussed above. RIPK1 is expressed in
healthy cells at higher amounts due to its multi-functionality [2][11][69][103]; during early
disease there may not be a large change in expression between infected and non-infected eyes
due to the abundance of readily available RIPK1. When infection and/or inflammation reach
critical levels though, cells likely respond in kind in order to clear the infection such as seen at
day 6 [2][43]. This spike in mRNA expression may be due to the combined effect of necroptosis
and other RIPK1 mediated pathways sent into transcriptional overdrive in order to increase
activity of certain pathways and to replenish the rapid turnover of RIPK1 [72]. In regards to
RIPK3 initial upregulation, there is not yet a confirmed consensus on the possible expression of
constitutive RIPK3 [77] or the lack thereof [70]. What is known is that low levels of RIPK3 are
still able to efficiently signal for necroptosis [72] [2][10] and it plays a part in the cross-talk
between cell death pathways, allowing for the cell to respond to different scenarios via
alternative immune/cell death signaling [2][76]. Necroptosis is also well known as an anti-viral
response [65]; transcriptional upregulation of RIPK3 mRNA at day 3 might be indicative of
cellular prep for necroptosis upon apoptosis inhibition [1][2]. Expression decreases by day 6 but
is still noticeably higher than control. MLKL on the other hand is constitutively expressed at
basal levels [71] but is needed in greater amounts in order to oligomerize, form pores and
successfully orchestrate cell death [2][11][64]. Again, likely in order to prep for potential
necroptosis activity, MLKL mRNA expression is also increased at day 3 and even further at day
6. Overall, the increased mRNA expression of all three might suggest significant stimulation of
necroptosis activity by day 6. Most notably, they show a noticeable decline in mRNA expression
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from day 6 to 10 (Fig. 14 and 16). The interim between these two time points happens to be
when the greatest changes to the retina occurs during MCMV retinitis. The decrease in
transcription of these cell death pathway molecules correlates with the decrease in active retinitis
once it has progressed to full retinal necrosis [1].
The assessment of MLKL expression via real-time RT-PCR quantitative analysis found
that mRNA was upregulated in MAIDS-related MCMV infected eyes. The comparison with
previous RIPK1/RIPK3 findings further links these necroptosis-associated molecules and known
disease progression. Due to the integral nature of MLKL, its increased mRNA expression makes
for the most definitive case of possible necroptosis so far. The translation of mRNA to actual
protein levels must first be determined before the presence of MLKL can be fully confirmed.
3.2

MLKL Protein Expression in MCMV Infected Eyes

Figure 17. MLKL protein is constitutively expressed in MAIDS-10 mice following
subretinal injection of either MCMV or media control.
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Western Blot. Top: bar graph of quantified total protein levels at days 3, 6 and 10 post
MCMV infection (dpi) compared to contralateral mock non-infected eyes (media
injected) with total % of ubiquitous housekeeping molecule GAPDH as a control for each
sample. Bottom: blotted protein; band density measured in ImageJ to quantify. Statistical
analysis via student T-test.
In necroptosis cell death signaling, MLKL is synonymous with the pathway more so than
RIPK1 and RIPK3 [78][79]. It is also linked to RIPK3 activity in which one RIPK3 molecule
can activate several MLKL via phosphorylation [2][11]. To function as the cell executioner,
several active MLKL must form an oligomer [2][64]. MLKL mRNA must then correlate to an
increased concentration of MLKL protein in order to support necroptosis cell death [64]. To
further evaluate relevance of mRNA upregulation, total MLKL protein concentration was
quantified via western blot to confirm the presence of this death determinant necroptosisassociated molecule in MAIDS-related MCMV retinitis eyes [11][64][65].
Whole eyes again were taken at the same time points, homogenized and prepped for
western blot against a phospho S345 MLKL antibody. Each sample tested consisted of a pool of
5-10 animals. Results for MCMV eyes were compared directly to mock infected eyes by band
density and graphed as a % of the control, GAPDH (Fig. 17). MLKL protein is constitutively
expressed in mock injected eyes at all time points, and although not significantly different, there
appears to be a trend of increased MLKL protein production in MCMV infected eyes when
compared to the media injected controls. It is possible that MCMV infected eyes may not show
substantially increased levels of MLKL protein due to alternative activation of MLKL or protein
localization to specific areas of tissue. It is of interest to note that the MLKL antibody used is
specific to phosphorylated MLKL at the 345 serine residue which is thought to signify its active
state. This phosphorylation site is independent of two other phosphorylation sites along the
activation loop of MLKL – Ser347, Th349 [74]. While there is disagreement on the necessity of
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Th349 phosphorylation for activation [65][74], Ser347 has been found to be necessary for
oligomerization [74][79]. Even with Ser347 phosphorylation, the ability to form oligomers is
further blocked until a critical threshold of MILKL is reached [71]. Structurally, MLKL contains
a c-terminal psuedokinase domain with an activation loop, a hinge and an attached N-terminal
4HB ‘killing’ domain [75][79]. When it is phosphorylated at its active loop, a conformational
change moves the C-terminal and N-terminal apart [75][92]. The 4HB domain can then associate
with the membrane through its two charged residue faces [70][75]. That being said, small
inhibitory molecules can bind at the activation loop concurrently to phosphorylation activation
[75][79]. These small molecules, such as ATP, can prevent conformational change and
subsequent oligomerization/cell death [71][75]. MLKL can still translocate to the membrane but
that alone is not sufficient to induce cell death [92]. Therefore, P345 MLKL might not always
equate to active/functioning MLKL. Validation of other MLKL antibodies would be useful in
elucidating the exact mechanism of MLKL involvement in MCMV infected eyes.
Constitutive expression of MLKL and other unknown effectors above threshold levels is
maintained by constitutive IFN signaling [70][71]. This mechanism of cellular homeostasis is
responsible for endosome activity and extracellular vesicle formation by MLKL [70]. Normally
autocrine IFN signaling works through the cGAS – Sting DNA sensor pathway to respond to
DNA damage, however, it can also respond to viral DNA and induce necroptosis augmentation
[71]. This occurs commonly in autoimmune and viral mediated cases and primes cells for
necroptosis [71]. In the case of MLKL activation, IFN signaling can either inhibit its activity
through small molecule binding [79] or utilize it for enhanced extracellular vesicle formation
[71]. For the latter, this enhanced activity helps maintain homeostasis in a stressed cell and/or
facilitates the release of cytokines (ex: IL-1beta) – more interestingly, it also removes excess
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activated MLKL in an effort to hold off necroptotic cell death [70][71]. Depending on cell type
and the reason for necroptosis priming in the cell, some never succumb and instead are able to
reestablish homeostasis [70]. The immunomodulation and suppression that results from MAIDS
may be priming cells for heightened responses to normal cell housekeeping activity. The mock
infected eyes could very well be displaying active MLKL without undergoing cell death in the
retina.
While presence of MLKL can signify programmed necroptosis, total amount of protein
should not be taken to equate to levels of necroptosis activity in a 1:1 ratio. Western blots for
RIPK1 and RIPK3 (not shown) were indicative of increased total protein in MCMV infected
whole eyes. RIPK1 showed only cleaved protein until day 10, at which time both a cleaved and
full protein appeared. Cleavage is usually a sign of some sort of caspase 8 mediated activity such
as apoptosis or NF-kB mediated cell survival/inflammation [43][69][72]. That considered
together with the eventual shift to non-cleaved RIPK1 could be suggestive of either simultaneous
apoptosis necroptosis or early apoptosis secondary necroptosis; regardless the ultimate outcome
is necroptotic cell death [2][73][97]. If apoptosis was the main or sole cell death pathway at play,
we would expect to see cleaved RIPK3 and MLKL [43][73][81]. RIPK3 also had two bands at
different molecular weights. A band with a higher than normal RIPK3 weight was shown very
prominently at day 3 and increased in size by day 10. The normal RIPK3 band was barely visible
at day 3 but did increase in density by day 10. While it is difficult to accurately predict what the
heavier RIPK3 protein is, there is at least some evidence for the existence of two RIPK3
isoforms [76]. Alternatively, post translational modifications are not uncommon during RIPK3
signaling and regulation; phosphorylation, ubiquitination or oligomerization may have resulted
in a heavier protein [99]. While the presence of these necroptosis related proteins in MCMV

35

infected eyes indicate the possible stimulation of the necroptosis pathway, protein level alone
fails to tell us if these proteins are functionally responsible for the observed MCMV retinitis
pathology, nor does it actually localize them to the retina.
4

LOCALIZED EXPRESSION OF NECROPTOSIS-ASSOCIATED MOLECULES IN
THE RETINA FOLLOWING MCMV INFECTION OF MAIDS-10 MICE
Immunohistochemical staining (IHC) allows for the localization of target molecules to

specific areas of tissue [40]. Using fluorescently labeled antibodies (Fig. 18) differential
patterning of molecules can be visualized across tissue and during different time points in disease
pathogenesis [41]. The amount and location of a molecule of interest can thus be qualitatively
assessed. This makes IHC an incredibly useful technique that is commonly used in disease
pathology studies [41][52]. Therefore to confirm that mRNA and total protein findings associate
with the retinitis disease model during MAIDS-related MCMV infection, localized staining of
necroptosis-associated molecules at the retina was necessary.

Figure 18. Indirect Immunofluorescence.
IHC staining that uses a primary antibody to bind to the antigen and then a fluorescently
labeled secondary antibody to bind to the primary antibody. In this study: antigen (mouse
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tissue) > anti-antigen primary antibody (hosted in rabbit) > anti-rabbit secondary
antibody labeled with Cy3 (hosted in goat). Modified from [36].
MCMV and contralateral-mock infected whole eyes were paraffin embedded eyes and
sectioned then stained using specific antibodies for RIPK1, RIPK3 and MLKL respectively (Fig.
18). Day 6 and day 10 post-infected eye sections were examined with day 6 displaying retinal
folding and day 10 displaying full retinal necrosis. These time points were selected in accordance
with the observed largest change in disease state indicated by mRNA results (Fig. 14) (Fig. 16)
and disease pathology in this model (Fig. 6). Results from MCMV eyes were normalized to
mock infected (media injected) eyes and to an isotype negative control. It was expected that
RIPK1, RIPK3 and MLKL expression would be upregulated in the retina during MAIDS-related
MCMV infection.
While IHC is integral for confirmation of localization to the site of interest, it is not
without its drawbacks. Due to antibody difficulty in binding effectively to antigens in tissue
[17][32] there occasionally might be a loss of signal and the representation that certain molecules
of interest are under-expressed. Additionally, issues can arise when diseased tissue is normalized
to control tissue. Mock infected sections do not exhibit retinitis pathology however, they may be
subject to inflammatory processes mediated by local tissue injury from the injection itself and/or
can be subject to such problems as retinal detachment which is associated with necroptotic cell
death [7][8]. Furthermore, in in-bred lab strains of mice, there could be possible
inflammatory/immune related over-reactions triggered by this event or already in process due to
the normal environmental stressors the eye undergoes [35]. This is due to the immunomodulatory
nature of inbreeding-depression and other genetic effects [31]. Aside from any additional
immune pressures mediated by this model, there is also a case to be made for normal levels of
cell death undergone by healthy tissues and even constitutive or alternative expression of certain
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molecules outside of active cell death signaling [2][33][45][65][69]. In part, healthy mock
infected tissue could exhibit observable levels of RIPK1, RIPK3 and MLKL expression that has
to be accounted for by normalizing and thus potentially reducing observable true expression in
diseased tissue. IHC provides final confirmation of pathological association but is done with
support from mRNA and total protein data in order to form a more complete picture of
necroptosis associated cell death. Overall, it was indeed found that MCMV infected retinas
expressed more RIPK1, RIPK3 and MLKL; especially at day 6 post-MCMV infection.
Necroptosis signaling appears to be present during disease pathogenesis and could be inferred to
be actively inducing cell death during the retinal destruction apparent in this model.

4.1

RIPK1 Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
Presence of RIPK1 protein in the retina was qualitatively evaluated via IHC to determine

what differences, if any, there were in RIPK1 localized activity across MCMV infected and noninfected retina at different time points. As RIPK1 is also associated with apoptosis cell death
signaling [2][42], its expression alone doesn’t determine what cellular death machinery is at
work. However, RIPK1 is the branching off point of many cellular signaling pathways:
apoptosis, necroptosis, cell survival and cytokine release through NFkβ [43][69]. Meaning
cellular activity in response to different stimuli can have differential effects on RIPK1 that then
determine its downstream signaling [2][8][10]. RIPK1 is an important molecule in understanding
what other players may be at work or inhibited during certain cellular processes. It can also serve
as a good indicator of overall initiation of programmed death signaling when tissue destruction is
observed. Most importantly, as it is associated with necroptosis classical signaling [2][11],
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RIPK1 expression in addition to RIPK3 and MLKL expression suggests necroptosis cell death
signaling.
At day 6 post-MCMV infection, RIPK1 is expressed in all retinal layers in comparison to
media injected eyes (Fig. 19). Of note is the expression of RIPK1 in the photoreceptor bodies
(rods and cones) of the media injected eyes. Expression was high enough that it could not be
normalized to black without losing all signaling in the MCMV infected retinas. This might
indicate some increased constitutive expression, though what RIPK1 mediated activity, if any, is
underway is unknown. However, photoreceptor bodies of MCMV infected retinas seem to have
even higher levels of RIPK1 expression. This increased expression seems congruent with the
dysregulated and diseased state observed in this layer, signifying active cell death. By day 10
(Fig. 20), full retinal destruction can be seen as the retina is no longer organized into discernable
layers. RIPK1 is still shown to be expressed, although in decreased amounts due to general
reduced cellular presence and activity consistent with end-stage disease. What little cell death
still underway appears at least partly RIPK1 related. In regards to non-diseased tissue,
photoreceptor bodies from media injected eyes again express RIPK1, further supporting potential
constitutive expression. All together, these results show that RIPK1 is up-regulated during day 6
and 10 MCMV induced retinitis in support of mRNA findings (Fig. 14). This increased
expression is clear despite possible issues discussed previously as well as other prospective
difficulties arising from RIPK1 post translational modification [99], reduced antibody binding at
the intracellular level [17][32][36] and/or protein degradation after cell lysis [93][99].
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Figure 19. RIPK1 expression in the retina of MAIDS-10 mice Day 6 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of RIPK1 protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact.
Retinal folding is characteristic of 6 days post MCMV infection (dpi).
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Figure 20. RIPK1 expression in the retina of MAIDS-10 mice Day 10 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of RIPK1 protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact.
Retinal folding is characteristic of 6 days post MCMV infection (dpi).
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4.2

RIPK3 Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
To further support the idea of necroptosis cell death signaling in MAIDS-related MCMV

retinitis, RIPK3 localization was expected to follow RIPK1 IHC findings. RIPK3 is more
associated with necroptosis and is often the alternative means of inducing cell death when
apoptosis is otherwise inhibited [2][8][10]. It has also been found to modulate cellular activity in
other ways before finally mediating cell death [43][76]. That being said, RIPK3 is not as widely
used as RIPK1 [103] and appears to be dispensable for most cellular activity [76]. Even during
necroptosis signaling it takes only a few active RIPK3 to transiently bind to and phosphorylate
numerous MLKL [79]. So RIPK3 does not necessarily have to be greatly expressed to efficiently
induce signal transduction along its pathway.
According to mRNA, RIPK3 is expressed in MCMV infected eyes even if at low
amounts (Fig. 14). To determine if that translated into protein localized to the retina, IHC was
done. At day 6 post-MCMV infection, RIPK3 is indeed expressed in the retina even if at minimal
levels compared to media injected (Fig. 21). Its presence is far more disperse that that of RIPK1
which evenly presented itself throughout the retinal layers. By day 10, there is a dramatic
decrease in expression but with some RIPK3 still present as compared to media injected (Fig.
22). It still occurs in a disperse manner whereas, at this time RIPK1 was strongly expressed in a
few focused sites. The differential localization of RIPK1 and RIPK3 at day 10 may be related to
simultaneous or early apoptosis, secondary necroptosis [2][73] and/or RIPK1 independent
necroptosis coming more into play [72]. As discussed before, low RIPK3 expression in general
could be due to the relatively efficient nature of RIPK3 in effecting downstream signal
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transduction players; so less is needed. Or it may also be indicative of under-representation of
true levels because of post translational modification activity [99], rapid protein degradation after
use or cell lysis [77][81] and/or difficulty of intracellular antigen antibody binding [17][32][36].
In examination of media injected eyes, it was appeared that there may be some slight constituent
RIPK3 expressed in the photoreceptor bodies such as was found with RIPK1. Overall, results
indicate that RIPK3 is upregulated in the retina during MAIDS-related MCMV retinitis; a good
but not confirmatory predictor of potential necroptotic cell death activity.
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Figure 21. RIPK3 expression in the retina of MAIDS-10 mice Day 6 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of RIPK3 protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 22. RIPK3 expression in the retina of MAIDS-10 mice Day 10 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of RIPK3 protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact
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4.3

MLKL Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
Lastly, MLKL presence in the retina was investigated as a follow up to RIPK1 and

RIPK3 data. The interactions between RIPK1, RIPK3, MLKL and subsequent signaling
mechanisms are not yet fully understood; MLKL in particular is still a subject of much interest
and new findings [65]. However, MLKL is currently known to be predominantly related to
necroptosis and is the final step in initiating cell death [64][65][77]. In conjunction with RIPK1
and RIPK3 IHC findings, its presence could confirm cell death via necroptosis. Its absence on
the other hand would definitively rule out necroptosis as a possible effector of retinal destruction
[77]. Not only is MLKL integral to the final step in cell death but it also is responsible for the
characteristic necroptosis manner of cellular death that is unique among programmed cell death
pathways [5][43][65]. Overall, MLKL is the final clue in putting together a complete picture of
necroptosis induced disease pathogenesis in MAIDS-related MCMV retinitis.
A potentially active form of MLKL was stained for via one of its phosphorylation sites
(345). While this alone is not fully indicative of active MLKL [65][74], it can be valuable when
taken into consideration along with cellular location of stained MLKL. Investigation by IHC at
day 6 post-MCMV infection, found MLKL to be highly and evenly expressed in all nuclear
retinal layers except in the ganglion layer where it was expressed at reduced levels (Fig. 23); this
is suggestive of dominantly active necroptosis signaling and cell death in all but the ganglion
cells. Of interest is the apparent association of MLKL with the plasma membrane of the retinal
cells as exhibited by the circular periphery cell staining seen. As MLKL is translocated to the
plasma membrane to form pores and effect final cell lysis [64], this is solid evidence of
necroptosis activity in progress. MLKL was also expressed in the photoreceptor bodies of
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MCMV infected retinas but not in healthy retinas unlike RIPK1 and RIPK3. By comparison,
retina from media injected eyes do not exhibit MLKL expression in any amount or location. By
day 10, at sites of full retinal necrosis, there is still clear expression of MLKL in focused
locations and in a more widespread pattern than RIPK1 (Fig. 24). However, just as with RIPK1
and RIPK3, there is a general reduction in expression due to complete retinal destruction nearing.
Again, there is no expression in retina of media injected eyes. MLKL retinal expression is
apparently upregulated by MCMV infection. It appears to be more highly expressed than either
RIPK1 or RIPK3; perhaps just as a matter of greater MLKL needed to efficiently participate in
signaling and cell death. Alternatively it might be due to the aforementioned potential issues that
could affect RIPK1/RIPK3 staining; in that case, MLKL would likely be easier to stain as it
associates with and dysregulates the membrane [64]. As the last downstream signaling/effector
protein involved, it is also possible that the timing of major changes in disease state coincide
with MLKL activity at its peak as opposed to the earlier involvement of RIPK1 and RIPK3.
Regardless of any such issues though, the abundant MLKL expressed in MAIDS-related MCMV
infected retinas indicates necroptotic cell death involvement in MCMV retinitis.
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Figure 23. MLKL expression in the retina of MAIDS-10 mice Day 6 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of MLKL protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 24. MLKL expression in the retina of MAIDS-10 mice Day 10 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of MLKL protein (red) and counterstained with
DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control. 3rd row: non-infected control (media injected) with primary antibody
4th row: media negative isotype control
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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5

LOCALIZED EXPRESSION OF PYROPTOSIS-ASSOCIATED MOLECULES IN
THE RETINA FOLLOWING MCMV INFECTION OF MAIDS-10 MICE
As addressed before, apoptosis and necroptosis were not the only programmed cell death

pathways suspected to be involved in the pathogenesis of MAIDS-related MCMV retinitis [1].
The inflammatory disease state observed during MCMV retinitis suggests the additional
involvement of pyroptosis cell death [2]. Similar to apoptosis, it is a caspase dependent signaling
pathway; though the induction of cell death through membrane pore formation is more
reminiscent of necroptosis [1][2][27]. That being said, pyroptosis is a characterized by a
distinctive style of cell death. Caspase 1, caspase 11 and GSDMD are widely recognized as
significant intracellular pyroptosis facilitators [50] when coupled with, IL-1β and IL-18
activation and release [2][27][34][53][54]. Canonical pyroptosis is considered the classical
pathway in which caspase 1 activation of GSDMD and IL-1β/IL-18 prompts a highly
inflammatory form of programmed cell death [2]. Non-canonical pyroptosis on the other hand is
affected by caspase 11 which is only capable of GSDMD activation and cell death that results in
non-specific DAMPS inflammation [2]. Differential signaling permits a more adaptive response
to pathogenic threats and is dependent on type of stimuli; thus both are of interest in disease
pathology investigations [2][53][56].
Previous work found pyroptosis-associated mRNA and total protein to be upregulated [1] in
MCMV infected eyes (Fig. 25) (Fig. 26) (the rest performed by Jessica Carter under the direction
of Dr. Richard D. Dix, Georgia State University-manuscript in progress). This was supportive of
pyroptosis activity during MCMV infection but was not definitive. [37][68]. Localization of
protein to areas of disease pathology is necessary to assess involvement during disease
pathogenesis [40][41][52]. Therefore, to confirm previous findings of pyroptosis signaling
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during MAIDS-related MCMV infection, pyroptosis-associated proteins were evaluated by IHC
in retinas of MCMV and mock infected eyes. It was expected that pyroptosis-associated proteins
would be found stimulated in the retinas of MCMV infected eyes.
To qualitatively assess and localize caspase 1, caspase 11, GSDMD, IL-1β and IL-18 in
retinal tissue, MCMV and contralateral-mock infected whole eyes were formalin fixed, paraffin
embedded, sectioned and then stained as described. Primary antibodies specific to protein were
used followed by a fluorescently labeled secondary antibody (Fig. 18) to visualize each protein
of interest separately. Just as with prior IHC work, day 6 and day 10 post-infected eye sections
were again examined. Results from MCMV eyes were normalized to mock infected (media
injected) eyes and to an isotype negative control. For the most part, it was found that MCMV
infected retinas expressed minimal amounts of investigated pyroptosis-associated molecules at
day 6; expression of GSDMD, IL-1β and IL-18 appeared to increase by day 10 however. These
low levels of expression could be true representations of pyroptosis intracellular signaling,
signifying marginal involvement of pyroptosis cell death in MCMV retinitis. Alternatively,
pyroptosis may be active at different time points; the increased expression at day 10 may indicate
a different temporal expression than what was observed for necroptosis. Regardless, pyroptosis
signaling does appear to be at least slightly active and thus may be responsible for some of the
cell death activity observed in MAIDS-related MCMV retinitis.
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Figure 25. Caspase 1 mRNA expression in MAIDS-10 subretinally infected eyes
compared with media control eyes.
Days 3, 6 and 10 post MCMV infection are shown. Values represent mRNA fold change
of MCMV infected eyes compared to media injected control eyes. Expression of mRNA
quantified by real-time RT-PCR and statistically analyzed by student T test with P values
≤0.05 being significant **p≤0.001, *p≤0.05 (n=5). Caspase 1 mRNA shows a significant
upregulation at 6 dpi and down regulation by 10 dpi. These experiments were performed
by Dr. Hsin Chien under the direction of Dr. Richard D. Dix, Georgia State University
[1].

Figure 26. Cleaved caspase 11 protein in MAIDS-10 mice following subretinal injection
of either MCMV or media control.
Western Blot. Top: bar graph of quantified total protein levels at days 3, 6 and 10 post
MCMV infection (dpi) compared to contralateral mock non-infected eyes (media
injected) with total % of ubiquitous housekeeping molecule GAPDH as a control for each
sample. MCMV infected eyes expressed only slightly more protein than the mock eyes.
Bottom: blotted protein; band density measured in ImageJ to quantify. Statistical analysis
via student T-test.
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5.1

Caspase 1 Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
Qualitative examination of caspase 1 localization at the retina was done to assess

potential pyroptosis activity in MCMV infected eyes compared to mock infected (media
injected) eyes. Caspase 1 is not involved in either apoptosis or necroptosis [51]. Furthermore,
canonical pyroptosis is caspase 1 dependent [51]. As such, it is considered a specific pyroptosisassociated molecule and its presence in diseased tissue is very telling. Caspase 1 is activated by
autocatalytic cleavage of pro-caspase 1 after inflammasome recruitment; the inflammasome is
itself assembled in response to a number of stimuli such as dsDNA, PAMPS, toxins, ATP and/or
pathogen stimulation [2][27][50]. After caspase 1 is activated, it directly initiates pyroptosis
activities through the cleavage and activation of GSDMD, IL-1β and IL-18 [34][2][27][56]. The
end result of which is membrane pore formation and secretion of inflammatory cytokines before
cell death [2][27]. This canonical pathway is essential for the cytokine specific inflammatory
response often induced by pyroptosis [34][53]. However, a general inflammatory state is also
induced with the fulfillment of cell death and DAMPS release [56][2][27]. Altogether, the
heightened inflammatory state induced by caspase 1 canonical pyroptosis cell death is a potent
means of defense against pathogens [27].
Previous caspase 1 mRNA demonstrated increased expression during MAIDS-related
MCMV infection, especially at day 6 post infection (Fig. 25); this was further supported by total
protein work (performed by Jessica Carter et al.). To confirm that this expression was at the
retina, IHC staining was indispensable. IHC results at day 6 post-MCMV infection showed low
levels of visible expression as compared to retina from media injected eyes (Fig. 27). Expression,
while very minimal, was evenly distributed throughout the retina in all layers. By day 10,
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expression was reduced throughout the retina but showed heightened expression in a few
concentrated areas (Fig. 28). These observations indicate that MCMV infection stimulates
caspase 1 production at low levels during retinitis progression. This could be indicative of true
caspase 1 expression but alternatively might indicate staining issues arising from poor antibody
availability, protein degradation and difficulty accessing intracellular proteins [17][32][37].
Further, it is entirely possible that the mRNA and total protein findings came from other areas of
the eye; again supporting low expression in the retina. Day 6 results could more specifically
imply that pro-caspase 1 is upregulated in retinal cells upon initial disease insult but otherwise
remains inactive [106]. Meaning that they are not yet associated with inflammasomes or visibly
concentrated around them [2][27][106]. Additionally, a single caspase 1 is able to activate
multiple IL-1β during pyroptosis [34][53]; as such, this could explain why overall caspase 1
expression is low. Thus caspase 1 may remain relatively innocuous in its inactive state, giving
rise to the even dispersal of expression throughout the retina seen at day 6. Overall, caspase 1
IHC staining seems to be characteristic of low but even expression across tissues in mild or nondiseased states [107]. Conversely, by day 10 it appears that caspase 1 exhibits some increased
expression. On first consideration it appears that pyroptosis, as it relates to main initiator caspase
1, may occur later than apoptosis/necroptosis. Further thought however brings to mind the fact
that caspase 1 activity can continue right up until cell death [2][11][34]; therefore it is not always
an accurate indicator of initial pyroptosis induction. So while the idea of late onset pyroptosis
could still be valid, it can’t be definitively confirmed from this data. That said, caspase 1
expression by day 10 could be the result of pro-caspase 1 inflammasome recruitment and
activation as it serves to concentrate caspase 1 [2][34]. Taking a step back to day 6 caspase 1
expression, it is possible that many of the retinal cells degraded pro-caspase 1 in favor of other
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cell death pathways more immediately available [2]. Those that didn’t may be the cells that
exhibited increased caspase 1 by day 10. Even if day 6 caspase 1 is in fact expressed in the active
form, it does not take away from day 10 changes but does suggest that caspase 1 mediated
pyroptosis is minimally at play early on in disease pathogenesis. Given that canonical pyroptosis
needs two separate stimuli to fully induce activity, it may be that the initial disease state provides
for very few pyroptosis specific stimuli – enough to stimulate transcriptional activity and
produce inactive forms of the proteins involved but not enough to induce catalytic activity in
most of the cells [106]. Further inflammatory disease progression likely provides for more
pyroptosis activating stimuli and thus increased levels of caspase 1 activation to facilitate further
pyroptosis in what remains of the retina [2][27][43][50][53]. Of final interest is a proposed
alternative mechanism for executing cell death within the canonical pathway through the use of
IL-1b autocrine stimulation and subsequent pyroptosome formation, a poly ASC inflammasomelike complex that acts on caspase 1 [111]. Caspase 1 activity can be modulated a number of ways
by pyroptosome transient recruitment and activation or complex formation [108][109][110];
most commonly it inhibits the ability of caspase 1 to mediate cytokine activation but accelerates
its GSDMD cleavage and cell death associated activity [110][111]. The occurrence of which
takes place after prior inflammasome caspase 1 pyroptosis activity and cytokine activation; the
release and autocrine signaling of IL-1b potentiates this particular method of pyroptotic cell
death [111]. Presence of and co-association with pyroptosome are usually observed as ‘specks’
[109].
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Figure 27. Caspase 1 expression in the retina of MAIDS-10 mice Day 6 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of caspase 1 protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 6 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 28. Caspase 1 expression in the retina of MAIDS-10 mice Day 10 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of caspase 1 protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 10 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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5.2

Caspase 11 Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
While caspase 1 is integral to canonical pyroptosis, caspase 11 is equally associated with

the non-canonical pathway [2]. As discussed earlier, the non-canonical pathway only involves
pyroptotic characterized cell death without the release of inflammatory cytokines [2][27].
Caspase 1 and 11 are thus both capable of executing pyroptosis but have also been known to
work together [56]. Unlike caspase 1 though, caspase 11 can be cleaved and activated via
bacterial LPS (lipopolysaccharide) without inflammasome involvement; the exact mechanism of
which is currently unknown [2][27]. Consequently the sole presence of caspase 11 may be
indicative of only a bacterial infection as opposed to other means of cellular insult [2][50]. In
relation to MCMV mediated infection, caspase 11 would thus be considered a potential but not
necessary player. Post activation, it can cleave GSDMD which leads to pore formation and
eventual cell death [2][27][56]. It is important to note though that caspase 11 is currently under
investigation for its potential to assist in caspase 1 activation and signaling [113]. Ultimately,
caspase 11 signaling can act as an additional means to execute pyroptosis but without the
specific inflammatory response achieved by cytokine activation and release [56].
Total protein findings showed increased protein levels at day 6 MCMV infection in
whole eyes (Fig. 26) which was also supported by mRNA findings (performed by Jessica Carter
et al.). Further work in IHC staining of the retina revealed several clues in the possible functional
activity of caspase 11 in this disease model. To note though, due to a lack availability, the
caspase 11 antibody was not specific to just the cleaved/active form. That in addition to potential
issues already discussed ad nauseum for caspase 1 may misrepresent actual levels of active
caspase 11. However, previous data and caspase 1 findings were integral in the formation of
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reasonable explanations into caspase 11 expression and activity during disease progression.
Protein localization revealed that caspase 11 overall shows even less upregulation than that of
caspase 1. At day 6 MCMV infection, there was minimal protein exhibited in the retina except
for a few of what appeared to be ‘specks’. While it has been seen that caspase 1 can be often
associated with pyroptosome ‘specks’ [108][109], both can also be expressed without coexpression of the other [110]. Aside from the poly-ASC base complex, pyroptosome inclusion of
certain inflammasome associated proteins and even other caspases can be variable and largely
dependent on the type of cellular insult/stimuli [109][110]. It is suggested though that
pyroptosome assembly can only occur with canonical pyroptosis associated stimulation and not
in LPS stimulated caspase 11 non-canonical pyroptosis [108]. However, given that pyroptosis
signaling can involve the interplay of both canonical and non-canonical pathways and that
regardless it needs at least two stimuli to proceed to actual pyroptotic activity [106], early
caspase 11 presence should not automatically preclude pyroptosome assembly. And while the
mechanism and exact means of association is unknown, caspase 11 itself has additionally been
implicated in inflammasome involvement [113]. This opens the door for its possible
pyroptosome involvement as well; though it may still necessitate caspase 1 participation and/or
alternative non-LPS cellular stimulation. Therefore the ‘speck’-like caspase 11 pattern observed
in day 6 MCMV infected retinas may truly represent pyroptosome formation and co-expression
as a functional indicator of pyroptosis activity. As briefly mentioned before, secondary
upregulation of caspase 1 (Fig. 28) may be correlated with pyroptosome mediated activation
through only a transient interaction which would explain the apparent lack of a ‘speck’ pattern.
Alternatively, this ‘speck’ pattern may be another super-molecular formation altogether such as
an active caspase 11 oligomer complex [112] which is supportive still of a rapid initial caspase
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11 response. Regardless of the mode of expression however, caspase 11 protein is no longer seen
by day 10 MCMV infection as compared to mock infected retinas (Fig. 30). This occurs again in
contrast to caspase 1 activity, suggesting a possible sequential progression of non-canonical to
canonical pyroptosis activity in this disease model or caspase 11 interference in canonical
pyroptosis. More definitively the findings do show that caspase 11 is upregulated during the
progression MCMV infection.
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Figure 29. Caspase 11 expression in the retina of MAIDS-10 mice Day 6 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of caspase 11 protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 6 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 30. Caspase 11 expression in the retina of MAIDS-10 mice Day 10 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of caspase 11 protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 10 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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5.3

GSDMD Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
GSDMD is critical to the pore forming mechanism needed to finally drive pyroptotic

cells into death [2]. It was therefore qualitatively analyzed via IHC as its presence is
characteristic of only pyroptosis [2][27]. It’s interactions with Caspase 1 and 11 make it of
further interest as they both cleave and activate GSDMD separately [2][27][50]. Cleavage
results in the loss of GSDMD’s C-terminal end, leaving the active N-terminus to initiate final
pyroptosis activities. The N-terminus oligomerizes with other active GSDMD and translocates to
the membrane where it can form pores and ultimately cause cell death [2][27]. In comparison to
necroptosis, both it and MLKL fulfill the same end points in very similar ways [2]. However,
classical necroptosis cell death releases danger associated molecular proteins (DAMPS)/debris
from the cell [9]. Pyroptosis on the other hand relies on the GSDMD formed pores to release
Caspase 1 activated cytokines before ultimate cell death and release of its own DAMPS
[2][34][53][54]. Additionally, fewer GSDMD are needed to form pores to mediate cellular
destruction; these pores are much larger than those formed by MLKL [105]. So while there are
certainly similar processes that take place between the two cell death pathways, GSDMD is
integral for more than one pyroptotic process [27].
Again, as with the other pyroptosis molecules under investigation here, total protein and
mRNA findings GSDMD has been shown to be upregulated (performed by Jessica Carter et al.).
Such findings are highly indicative of pyroptosis pathway signaling/activity due to the uniquely
defining nature of GSDMD. However, its direct association with the actual disease state had yet
to be shown, necessitating investigation by IHC in MCMV infected retinas. Results do indicate
pyroptosis involvement as expressed by GSDMD protein localization in the retina during
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MCMV retinitis. GSDMD expression seems to follow along a similar trend as Caspase 1, but
with more apparent levels; this may be due to better antibody accessibility as GSDMD associates
with the cellular membrane. Day 6 saw significant increase in GSDMD expression with an even
presence throughout the diseased retina (Fig.31). By day 10, expression has decreased
throughout with the exception of highly concentrated areas of retina still undergoing active
retinitis progression (Fig. 32). Its presences is a clear indication MCMV induced pyroptosis
involvement during retinal destruction.
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Figure 31. GSDMD expression in the retina of MAIDS-10 mice Day 6 post-infection with
MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 6 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 32. GSDMD expression in the retina of MAIDS-10 mice Day 10 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 10 dpi caspase 1, caspase 11 and GSDMD). 3rd row: non-infected
control (media injected) with primary antibody
4th row: media negative isotype control (shared for caspase 1, caspase 11 and GSDMD)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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5.4

Interleukin 1β Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
In reference back to the main pyroptosis player - caspase 1 – and its primary role as an

activator of cytokines, we looked next at two pyroptosis-associated inflammatory cytokines such
as IL-1β and IL-18 [34][53]. As a key cytokines implicated in various immunomodulatory
processes, it is indicative of further induction of inflammatory action [53]. IL-1β in particular is
of interest due to its implications on inflammation induced or exacerbated diseases [54]. While it
is associated with many different cell types and disease, the common denominator appears
pyroptosis cell death activity [54]. Therefore, IL-1β is a good indicator of fully invested
pyroptosis signaling in particular cells in areas of inflammation and tissue destruction. Further, it
is currently thought that the pore forming GSDMD is integral for the release of IL-1β, at least in
terms of inflammatory progression in a diseased state. And in the typical way cells do multifunctionality, the mechanism by which GSDMD is cleaved also plays a part in the cleavage of
pro-IL-1β into its active form via caspase 1 (Fig. 10).
Following previous findings of increased total protein/mRNA in MCMV infected whole
eyes, we sought again to investigate if protein localization at diseased tissue correlated with the
other findings. IHC results at day 6 post MCMV infection in retinas show no significant
expression (Fig. 33) while day 10 expression is increased throughout with pockets of apparent
heightened activity (Fig. 34). This may be due to the necessity of a stimuli process cells use
before fully committing to cell death by pyroptosis [106]. Cytokine release does not occur until
after caspase 1 has cleaved and activated after the second stimuli [51]. These findings overall
suggest that an inflammatory process is taking place and is stimulated by MCMV infection. This
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further supports not only pyroptosis activity in the form of cell death but as a mediator of
inflammation in the diseased state.
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Figure 33. Interleukin 1β expression in the retina of MAIDS-10 mice Day 6 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 6 dpi IL-1β and IL-18). 3rd row: non-infected control (media injected)
with primary antibody
4th row: media negative isotype control (shared for 6 dpi IL-1β and IL-18)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 34. Interleukin 1β expression in the retina of MAIDS-10 mice Day 10 postinfection with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 10 dpi IL-1β and IL-18). 3rd row: non-infected control (media
injected) with primary antibody
4th row: media negative isotype control (shared for 10 dpi IL-1β and IL-18)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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5.5

Interleukin 18 Expression Following Ocular MCMV Infection at Days 6 and 10 PostInfection
Lastly, IL-18 is the second inflammatory cytokine commonly associated with pyroptosis

activity and was therefore of interest in the investigation of possible pyroptosis mediated tissue
destruction during MCMV retinitis [56]. As before, IHC was used to localize protein at the site
of disease in possible support of total protein and mRNA findings (not yet published). It, like IL1β, is in the IL-1 family and activated by caspase 1. In contrast however, it is constitutively
expressed in all cells thus making it a lesser target of interest in disease studies despite its role in
inducing inflammatory responses [54]. This is because it is usually kept in balance by a binding
protein (IL-18BP) and a resulting imbalance can lead to a severe inflammatory state, especially
in chronic disease [54]. At this time though, it is far easier to evaluate IL-18 levels in conjunction
with IL-1β rather than just alone. However in some diseases, it is being found that IL-18 is an
important initiator of the inflammatory process which makes it both a potential acute and chronic
disease cell death player as opposed to the slower to respond but seemingly potent IL-1β [55].
As with results for IL-1β, it too took a temporal expression pattern following increased
expression at day 10 (Fig. 35) as opposed to the minimal expression seen at day 6 (Fig. 36). For
the same reasons as seen with the expression of its co-cytokine, IL-18 is apparently released
more abundantly later along in the diseased progression induced by MCMV. Therefore it too is
also stimulated by MCMV infection of the retina where it mediates an inflammatory state as part
of the overall activity of pyroptosis.
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Figure 35. Interleukin 18 expression in the retina of MAIDS-10 mice Day 6 post-infection
with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 6 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 6 dpi IL-1β and IL-18). 3rd row: non-infected control (media injected)
with primary antibody
4th row: media negative isotype control (shared for 6 dpi IL-1β and IL-18)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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Figure 36. Interleukin 18 expression in the retina of MAIDS-10 mice Day 10 postinfection with MCMV or media control.
Whole eyes from MAIDS-10 mice were harvested at 10 dpi, fixed in 10% formalin, and
assessed by immunofluorescent staining of GSDMD protein (red) and counterstained
with DAPI (blue). Viewed at 40x magnification.
1st row: MCMV infected retina with primary antibody. 2nd row: MCMV negative isotype
control (shared for 10 dpi IL-1β and IL-18). 3rd row: non-infected control (media
injected) with primary antibody
4th row: media negative isotype control (shared for 10 dpi IL-1β and IL-18)
Key: star labels the photoreceptor side of the retina for orientation where still intact.
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6

DISCUSSION AND CONCLUSIONS

Aim 1 tested the central hypothesis that explored the role necroptosis has on CMV
retinitis in the murine model and in human patients, while Aim 2 tested the role of pyroptosis in
the same regard. Specific aim 1 hypothesis: Necroptosis molecules RIPK1, RIPK3 and MLKL
will be upregulated during MCMV retinitis in MAIDS model mice. Specific aim 2 hypothesis:
Pyroptosis molecules caspase 1, caspase11 and GSDMD will be upregulated during MCMV
retinitis in MAIDS model mice This study investigated the relationship between the potential
upregulation of programmed necroptotic and pyroptotic cell death and retinal degeneration in the
experimental murine model. Although a combination of previous mRNA and total protein
findings for necroptosis and pyroptosis-associated molecules were found to be stimulated during
MAIDS-related MCMV retinitis, the full extent of these cell death pathways in MCMV retinitis
had yet to be elucidated. Both aims were pursued when needed by assessment of mRNA and
total protein via real-time RT-PCR quantitative analysis and western blot respectively and
protein localization via IHC staining in the murine model eyes. The findings herein confirm that
necroptosis-associated RIP1, RIP3, MLKL and pyroptosis-associated caspase 1, caspase 11,
GSDMD, IL-1b and IL-18 were indeed stimulated during the progression of MAIDS-related
MCMV retinitis and that they precede retinal necrosis development. These findings and related
studies are essential in the accurate quantification of cell death players for anti-molecule targeted
therapies [17].
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